اختبار: العلاج بالنظائر المشعة A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Which of the following property of radiation is principally used in the treatment of tumors? Fluorescent effect Chemical effect Biologic effect Photographic effect 2. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Radiation pneumonitis Leukemia Myelosuppression Gastritis 3. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Bruising Fever Anemia Arrhythmia 4. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine Performing pulmonary function tests 5. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 50–100 mCi. 100–150 mCi. 150–200 mCi. 200–250 mCi. 6. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Super scan. Flare scan. Flare phenomenon. Super phenomenon. 7. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radiation therapy. Radiochemotherapy. Radioimmunotherapy. Antibody therapy. 8. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications Performing pulmonary function tests Blocking thyroid uptake of free radioiodine A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan 9. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Thyroiditis Hyperthyroidism Thyroid carcinoma Hypothyroidism 10. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Chemotherapy. Surgical removal. Fine needle aspiration biopsy. Radiation therapy. 1 out of 10 Time's upTime is Up! بواسطة ناصر المطيري|2021-09-20T14:25:06+03:00أبريل 26th, 2021|العلاج بالنظائر المشعة|لا توجد تعليقات شارك هذه الصفحة, واترك رأيك حول الموضوع باستخدام وسيلة التواصل التي تناسبك FacebookXLinkedInWhatsAppPinterestEmail عن: ناصر المطيري كبير أخصائيي الطب النووي في مستشفى حفر الباطن المركزي و مؤسس موقع نيوكليرمد. اترك تعليقاًCancel reply
اترك تعليقاً